THE ATG BASED MYELOABLATIVE CONDITIONING REGIMEN IS EFFECTIVE IN PATIENTS WITH RELAPSED OR HIGH-RISK T CELL LYMPHOMA

被引：0
|
作者：
Jun, Y. [1 ,2 ]
Chun, W. [1 ]
Shike, Y. [1 ]
Jieling, J. [1 ]
Liping, W. [1 ]
Yu, C. [1 ]
Jun, Y. [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 1, Hematol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 1, Hematolog, Shanghai, Peoples R China
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1700
引用
收藏
页码：664 / 665
页数：2
相关论文
共 50 条
  • [21] Intermediate intensity conditioning and T-cell replete allogeneic transplantation is effective in high-risk relapse and progressive disease of aggressive lymphoma
    Hasenkamp, J.
    Wulf, G.
    Goerlitz, A.
    Dreger, P.
    Schubert, J.
    Nickelsen, M.
    Truemper, L.
    Schmitz, N.
    Glass, B.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S249 - S249
  • [22] CYCLOPHOSPHAMIDE, MELPHALAN AND TBI AS CONDITIONING REGIMEN PRIOR TO TRANSPLANTATION FOR HIGH-RISK PATIENTS
    MARIT, G
    BOIRON, JM
    DAVID, B
    RICHAUD, P
    BROUSTET, A
    REIFFERS, J
    BONE MARROW TRANSPLANTATION, 1988, 3 : 315 - 315
  • [23] Thiotepa and cyclophosphamide as conditioning regimen for high-risk patients with hematological malignancies.
    Fabre, E
    Boiron, JM
    Pigneux, A
    Dazey, B
    Agape, P
    Cony-Makhoul, P
    Lacombe, F
    Bouzgarrou, R
    Reiffers, J
    BONE MARROW TRANSPLANTATION, 1998, 21 : S97 - S97
  • [24] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    M Iravani
    M R Evazi
    S A Mousavi
    A R Shamshiri
    M Tavakoli
    A Ashouri
    S Samiee
    B Chahardovali
    K Alimoghaddam
    S H Ghaffari
    A Ghavamzadeh
    Bone Marrow Transplantation, 2007, 40 : 105 - 110
  • [25] Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma
    Shabbir-Moosajee, Munira
    Jehangir, Samad
    Sawani, Sobiya
    Muhammed, Tariq
    Ali, Natasha
    Sheikh, Usman
    Adil, Salman
    BLOOD RESEARCH, 2019, 54 (02) : 108 - 113
  • [26] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    Iravani, M.
    Evazi, M. R.
    Mousavi, S. A.
    Shamshiri, A. R.
    Tavakoli, M.
    Ashouri, A.
    Samiee, S.
    Chahardovali, B.
    Alimoghaddam, K.
    Ghaffari, S. H.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2007, 40 (02) : 105 - 110
  • [27] ALLOGENEIC STEM CELL TRANSPLANTATION WITH REDUCED INTENSITY CONDITIONING REGIMEN IN PATIENTS WITH RELAPSED HODGKIN'S LYMPHOMA
    Marta Rivas, M.
    Berro, M.
    Virginia Prates, M.
    Yantorno, S.
    Milone, J.
    Lisa Basquiera, A.
    Adriana, B.
    Jose Garcia, J.
    Remaggi, G.
    Martinez Rolon, J.
    Burgos, R.
    Foncuberta, C.
    Feldman, L.
    Jaimovich, G.
    Real, J.
    Milovic, V.
    Arberbide, J.
    Makiya, M.
    Dibar, E.
    Kusminsky, G.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S172 - S173
  • [28] Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin's Lymphoma
    Rivas, Maria Marta
    Berro, Mariano
    Yantorno, Sebastian
    Prates, Maria Virginia
    Milone, Jorge H.
    Basquiera, Ana Lisa
    Berreta, Adriana
    Garcia, Juan
    Remaggi, Guillermina
    Rolon, Juliana Martinez
    Arbelbide, Jorge
    Makiya, Monica
    Dibar, Eduardo
    Requejo, Alejandro
    Feldman, Leonardo Julio, Sr.
    Milovic, Vera
    Foncuberta, Maria Cecilia
    Burgos, Ruben
    Kusminsky, Gustavo Daniel
    BLOOD, 2013, 122 (21)
  • [29] ALLOGENEIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED OR CHEMOREFRACTORY T-CELL LYMPHOMA: ROLE OF HIGH INTENSITY CONDITIONING
    Glass, B.
    Hasenkamp, J.
    Jung, W.
    Wilhelm, C.
    Held, G.
    Nickelsen, M.
    Pfreundschuh, M.
    Schmitz, N.
    Truemper, L.
    Wulf, G. G.
    ANNALS OF ONCOLOGY, 2011, 22 : 95 - 95
  • [30] High-risk of EBV lymphoma after allogeneic HSCT in adult lymphoma patients. The Swedish experience of myeloablative compared to reduced-intensity conditioning
    Hagglund, H
    Brune, M
    Oberg, G
    Hagberg, H
    Juliusson, G
    Wahlin, A
    Theorin, N
    Remberger, M
    Karolinska, EK
    BONE MARROW TRANSPLANTATION, 2005, 35 : S73 - S74
12345